Welcome to our dedicated page for Piedmont Lithium news (Ticker: PLL), a resource for investors and traders seeking the latest updates and insights on Piedmont Lithium stock.
Piedmont Lithium Inc. (symbol: PLL) is a U.S.-based company dedicated to creating a multi-asset, integrated lithium business. The company focuses on supplying lithium hydroxide, an essential material for the electric vehicle (EV) and battery manufacturing supply chains, supporting the development of a clean energy economy in North America.
Piedmont Lithium operates several key projects, including Carolina Lithium in Gaston County, North Carolina. This ambitious project aims to be a fully integrated spodumene ore-to-lithium hydroxide facility. Additionally, the company is developing the Tennessee Lithium project, a proposed merchant lithium hydroxide manufacturing plant located in McMinn County, Tennessee. Both projects are central to Piedmont Lithium's strategy to enhance U.S. energy security and contribute to global lithium supply.
As a development-stage company, Piedmont Lithium is committed to advancing its portfolio of wholly-owned projects. Their efforts are rooted in the mission to support the burgeoning demand for lithium in EVs and energy storage, pivotal in the transition to renewable energy sources.
The company has recently made significant strides in its projects, securing vital partnerships and investments. These collaborations are designed to accelerate the growth and operational capabilities of Piedmont Lithium, aligning with the rising market demand for sustainable energy solutions.
Financially, Piedmont Lithium is strategically positioned to capitalize on the growing lithium market. Through prudent management and focused development, the company aims to achieve substantial growth and deliver value to its stakeholders.
Pall Corporation has entered a strategic partnership with Single Use Support GmbH to improve the safe handling of biologics. The collaboration will focus on distributing the RoSS platform, enhancing Pall's integrated solutions for the biopharma industry. This initiative aims to provide a fully validated end-to-end solution, thereby facilitating the efficient delivery of life-saving drugs. Pall's investment and combined expertise promise to make these innovative solutions more accessible to global biopharma customers.
Piedmont Lithium Limited plans to re-domicile from Australia to the United States, transitioning its primary listing from the ASX to the Nasdaq, pending shareholder, regulatory, and court approvals. The proposed Scheme will see Piedmont USA become the parent company, allowing investors to receive shares accordingly. This move aims to attract more U.S. investors, facilitate access to capital, and enhance the company's structure for future strategic opportunities. The Board recommends shareholder support, with a vote expected in March 2021.
Piedmont Lithium Limited has secured an air permit from the North Carolina Department of Environmental Quality for its planned lithium hydroxide chemical plant in Kings Mountain, North Carolina. This significant milestone follows a detailed review of the permit application submitted in October 2020. The permit outlines emission limits and air cleaning operations for the facility. Alongside a previously received federal permit, Piedmont now possesses all essential permits for the construction of its integrated project, which aims to be the only spodumene-to-hydroxide project in the U.S.
Piedmont Lithium Limited has awarded the definitive feasibility study (DFS) for its spodumene concentrate operations in North Carolina to Primero Group and Marshall Miller & Associates. The DFS aims for production of 160,000 tonnes per year of SC6, with co-products including quartz and feldspar. Completion of the DFS is expected by mid-2021, followed by an investment decision. Piedmont is also set to start a DFS for a lithium chemical plant in Q1 2021, and anticipates beginning construction in mid-2021 to meet the growing lithium hydroxide demand expected in 2022-2023.
Piedmont Lithium Limited has partnered with SGS Canada to conduct a pilot-scale spodumene concentrator testwork program in Lakefield, Ontario. The initiative utilizes a 50-tonne bulk sample from the Piedmont Lithium Project in North Carolina, collected in February 2020. The pilot plant aims to produce spodumene concentrate with at least 6.0% Li2O and less than 1.0% Fe2O3. This pilot program is crucial for supporting the definitive feasibility study and detailed design engineering of the company's lithium operations.
Piedmont Lithium Limited (ASX: PLL; NASDAQ: PLL) reported significant progress in its September 2020 quarterly report. Major highlights include a binding agreement to supply spodumene concentrate to Tesla for five years, successful lithium hydroxide testwork from Piedmont's ore, and resuming drilling in the Carolina Tin-Spodumene Belt. Additionally, the company appointed a new VP of Sales & Marketing and completed a public offering, raising $57.5 million. These actions strengthen its balance sheet and advance plans to become the first new American lithium hydroxide producer in decades.
Piedmont Lithium Limited (Nasdaq:PLL; ASX:PLL) has announced the closing of its underwritten public offering of 2.3 million American Depositary Shares, yielding gross proceeds of $57.5 million. The offering, which included 300,000 additional ADSs, will fund the development of the Piedmont Lithium Project, including feasibility studies, exploration drilling, and permitting. Joint book-runners for the offering included Evercore ISI, Canaccord Genuity, and ThinkEquity. Further details and a final prospectus are available through the SEC and ASX websites.
Piedmont Lithium Limited (Nasdaq:PLL) has announced the pricing of a public offering of 2.0 million American Depositary Shares (ADSs) at $25.00 each, aiming for gross proceeds of $50 million. The offering will close on October 23, 2020, pending customary conditions. Additional 300,000 ADSs may be purchased by underwriters. Proceeds will support the development of the Piedmont Lithium Project, including feasibility studies and exploration drilling. The offering is made under an effective registration statement with the SEC.
Piedmont Lithium Limited (Nasdaq:PLL) has announced plans for a U.S. public offering of 1.5 million American Depositary Shares (ADSs), with each ADS representing 100 ordinary shares. The offering, dependent on market conditions, may allow underwriters to purchase an additional 225,000 ADSs. Proceeds will fund the Piedmont Lithium Project, including feasibility studies, testwork, permitting, and exploration drilling. The offering is conducted under an effective shelf registration statement filed with the SEC.
Piedmont Lithium Limited has signed a binding agreement with Tesla for the supply of spodumene concentrate (SC6) from its North Carolina deposit. This five-year deal involves a fixed-price commitment for about one-third of Piedmont’s planned SC6 production of 160,000 tonnes annually, potentially generating 10-20% of total revenues from its integrated project. The agreement is conditional on mutual agreement of a delivery start date between July 2022 and July 2023. CEO Keith D. Phillips emphasized the significance of this partnership in establishing a U.S. lithium supply chain.